Cardiotonic drugs are a class of medications primarily designed to enhance the contractile force of the heart muscle and improve its pumping efficiency. These drugs play a crucial role in the management of various cardiovascular conditions, particularly heart failure. By increasing the strength of each heartbeat, cardiotonic drugs help improve cardiac output, ensuring that the heart effectively pumps blood throughout the body. Digoxin, a well-known cardiotonic drug, is derived from the foxglove plant and has been used for centuries. It works by inhibiting a sodium-potassium pump, leading to an increase in intracellular calcium concentration, which, in turn, strengthens myocardial contractions. While cardiotonic drugs can be beneficial in certain clinical scenarios, their use requires careful monitoring due to the narrow therapeutic window and potential for toxicity. In modern medicine, these drugs are often prescribed in combination with other cardiovascular medications to optimize treatment outcomes for patients with heart-related conditions.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain